Dr. Shah is Founder and CEO of Novatherx, a life science company providing expertise, leadership and investment support to biotech and pharmaceutical companies advancing innovative therapeutics that address areas of critical unmet medical need.

Over the past 25 years, Dr. Shah has worked to advance novel therapies and lead companies in the life sciences area.  He is currently CEO of Glyscend Therapeutics, a clinical-stage biopharmaceutical company reshaping the treatment of metabolic disease with polymeric drugs targeting obesity and type 2 diabetes.  Prior to that, Dr. Shah was CEO of StrideBio, a next-generation gene therapy company with a structure guided AAV capsid engineering platform that was acquired by Ginkgo Bioworks.  He was also previously CEO of ARMGO Pharma, a biotechnology company launched from Columbia University developing novel small-molecule therapeutics to treat debilitating cardiac and rare muscle diseases.  Dr. Shah also served as CEO of Shionogi, Inc., where he expanded the US pharmaceutical business of Shionogi & Co., Ltd., growing from its inception as a small clinical development subsidiary to ultimately a fully integrated commercial entity with $400M in sales and over 400 employees.  At Shionogi he also led efforts to negotiate, structure, launch, and operate a highly successful joint venture between Shionogi and GSK/ ViiV, resulting in the discovery, development and commercialization of a novel HIV integrase inhibitor.  In addition, Dr. Shah was also previously co-founder and Chairman of Ezose Sciences, a high throughput glycomics company launched out of Hokkaido University pioneering novel techniques for glycoprotein biomarker discovery, and was acquired by Sumitomo Bakelite Corporation.

Dr. Shah began his career at McKinsey & Company, advising pharmaceutical and biotech clients on a wide range of R&D, commercial and corporate strategy matters.  He earned his Ph.D. degree in Molecular Biophysics and Biochemistry from Yale University and holds BA degrees in Mathematics and Biochemistry from the Integrated Science Program at Northwestern University.